United States · Pharmaceuticals startup
United States · Alnara Pharmaceuticals
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
Funding reportedLast round: Series B
Follow Alnara Pharmaceuticals and see its new rounds in your feed.Start following
What company datasets say Alnara Pharmaceuticals raised
Funding, as reported
Reported in all$55Min dollars
Rounds2
Last roundSeries B
Last round dateJan 2010
Investors listed5
Founders and team
From the SEC filings it signed: 3 on the team.
- Alexey MargolinExecutive Officer, Directori
- Lee BrettmanExecutive Officeri
- Robert GallottoExecutive Officeri
On the board, as filediAshley H. DombkowskiChristoph H. WestphalJames N. TopperRichard H. AldrichRobert H. Tepper
How it ended, so far
Exit
ExitBuyerPriceWhen
Pharmaceuticals in United States
Startups like it
AMAG PharmaceuticalsWaltham · founded 1981- PL DevelopmentsWestbury · founded 1988
Remedi SeniorCareBaltimore · founded 1954- Spectrum PharmaceuticalsLake Forest · founded 1987
- moksha8 PharmaceuticalsBerwyn · founded 2007
NeurelisSan Diego · founded 2007
Amplyx PharmaceuticalsSan Diego · founded 2006- Zosano PharmaFremont · founded 2006
Is this your company?
Add your raise, your deck and your story, and put Alnara Pharmaceuticals in front of investors. Or tell us what we have wrong.